By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Grifols 

4560 Horton Street

Emeryville  California  94608-2916  U.S.A.
Phone: 510-655-8730 Fax: n/a


SEARCH JOBS

Grifols has a history of more than 70 years of commitment to transfusion medicine and patient safety. Our broad range of innovative diagnostic solutions plays a key role in ensuring the availability of safe and compatible blood products in markets worldwide. Active in all the different areas of transfusion safety, we provide products and systems for blood collection, typing, screening and traceability. Today, thousands of blood banks and transfusion services around the world trust in Grifols' diagnostic products.


Key Statistics


Email:
Ownership: Public

Web Site: Grifols
Employees: 800
Symbol: GRFS
 



Industry
Diagnostics






Company News
Plasma Medication Manufacturer Grifols Opens State-Of-The-Art Facility In North Carolina, 200 New Jobs On The Horizon 6/17/2014 11:13:20 AM
Grifols Completes Patient Enrollment In Its Phase2/3 Psoriasis Trial; Final Results Are Expected In Q1 2015 6/17/2014 10:50:26 AM
TiGenix: Appoints Gri-Cel CEO Dirk Buscher And COO Jose Terencio To Board Of Directors Following Strategic Investment By Grifols 12/5/2013 9:36:31 AM
TiGenix Completes EUR 12 Million Capital Increase With Strategic Investor Grifols 11/22/2013 9:28:33 AM
Novartis AG (NVS) Sells Diagnostics Business Unit To Grifols For $1.68 Billion 11/11/2013 6:57:41 AM
Grifols Announces Launch of the SPIRIT Registry at the NHF Annual Meeting 10/4/2013 7:08:15 AM
Grifols and Aradigm Corporation (ARDM) Complete the Closing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin® 8/28/2013 10:38:04 AM
Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University 7/18/2013 9:28:30 AM
Grifols Study Demonstrates Higher Dose of PROLASTIN-C Increases Levels of Alpha1-PI to Within Normal Range in Patients With AAT Deficiency 5/22/2013 10:17:11 AM
Grifols Signs Deal to License Aradigm Corporation (ARDM)'s Pulmaquin for Up to $90.7 Million 5/21/2013 7:01:13 AM
123456
//-->